Audoin B, Zaaraoui W, Reuter F, Rico A, Malikova I, Confort-Gouny S, Cozzone PJ, Pelletier J, Ranjeva JP. Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis. J Neurol Neurosurg Psychiatry; 81: 690-5.
Balas M, Balash Y, Giladi N, Gurevich T. Cognition in multiple system atrophy: neuropsychological profile and interaction with mood. J Neural Transm; 117: 369-75.
Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Differential involvement of the periaqueductal gray in multiple system atrophy. Auton Neurosci; 158: 111-7.
Bloch F, Pichon B, Bonnet AM, Pichon J, Vidailhet M, Roze E, Perrigot M. Urodynamic analysis in multiple system atrophy: characterisation of detrusor-sphincter dyssynergia. J Neurol; 257: 1986-91.
Brooks JA, Houlden H, Melchers A, Islam AJ, Ding J, Li A, Paudel R, Revesz T, Holton JL, Wood N, Lees A, Singleton AB, Scholz SW. Mutational analysis of parkin and PINK1 in multiple system atrophy. Neurobiol Aging; 32: 548 e5-7.
Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain; 133: 2382-93.
Bukhatwa S, Zeng BY, Rose S, Jenner P. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Brain Res; 1326: 174-83.
Damon-Perriere N, Tison F, Meissner WG. [Multiple system atrophy]. Psychol Neuropsychiatr Vieil; 8: 179-91.
de Mello RA, Ferreira D, Dias da Costa JM, Rosas MJ, Quinaz JM. Multiple-system atrophy with cerebellar predominance presenting as respiratory insufficiency and vocal cords paralysis. Case Report Med; 2010.
Deguchi K, Ikeda K, Goto R, Tsukaguchi M, Urai Y, Kurokohchi K, Touge T, Mori N, Masaki T. The close relationship between life-threatening breathing disorders and urine storage dysfunction in multiple system atrophy. J Neurol; 257: 1287-92.
Di Filippo M, Floridi P, Rossi V, Mattucci E, Rossi A, Calabresi P, Tambasco N. A young patient with type C multiple system atrophy and hereditary hemochromatosis. J Neurol; 257: 294-5.
Dodel R, Spottke A, Gerhard A, Reuss A, Reinecker S, Schimke N, Trenkwalder C, Sixel-Doring F, Herting B, Kamm C, Gasser T, Sawires M, Geser F, Kollensperger M, Seppi K, Kloss M, Krause M, Daniels C, Deuschl G, Bottger S, Naumann M, Lipp A, Gruber D, Kupsch A, Du Y, Turkheimer F, Brooks DJ, Klockgether T, Poewe W, Wenning G, Schade-Brittinger C, Oertel WH, Eggert K. Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). Mov Disord; 25: 97-107.
Donadio V, Cortelli P, Elam M, Di Stasi V, Montagna P, Holmberg B, Giannoccaro MP, Bugiardini E, Avoni P, Baruzzi A, Liguori R. Autonomic innervation in multiple system atrophy and pure autonomic failure. J Neurol Neurosurg Psychiatry; 81: 1327-35.
Esterhammer R, Schocke M, Seppi K. Basal ganglia cellular pathology in multiple system atrophy, progressive supranuclear palsy and Parkinson disease. Can quantitative magnetic resonance spectroscopic imaging make the difference? Eur J Neurol; 17: 1111-2.
Finke C, Siebert E, Plotkin M, Wenning GK, Reuter U. Multiple system atrophy masking multiple sclerosis. Clin Neurol Neurosurg; 112: 59-61.
Flabeau O, Meissner WG, Tison F. Multiple system atrophy: current and future approaches to management. Ther Adv Neurol Disord; 3: 249-63.
Gama RL, Tavora DG, Bomfim RC, Silva CE, de Bruin VM, de Bruin PF. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study. Parkinsonism Relat Disord; 16: 275-9.
Gardner RC, Schmahmann JD. Arginine test is not reliable for diagnosing cerebellar multiple system atrophy. Ann Neurol; 67: 404-8.
Geser F, Malunda JA, Hurtig HI, Duda JE, Wenning GK, Gilman S, Low PA, Lee VM, Trojanowski JQ. Subcortical TDP-43 pathology occurs infrequently in multiple system atrophy. Neuropathol Appl Neurobiol.
Goricke B, Lingor P, Stadelmann-Nessler C, Bahr M, Kastrup A, Kermer P. Cerebellar-type multiple system atrophy presenting with leucoencephalopathy. J Neurol Neurosurg Psychiatry.
Guevara CA, Blain CR, Stahl D, Lythgoe DJ, Leigh PN, Barker GJ. Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Eur J Neurol; 17: 1193-202.
Hasegawa T, Baba T, Kobayashi M, Konno M, Sugeno N, Kikuchi A, Itoyama Y, Takeda A. Role of TPPP/p25 on alpha-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy. Neurochem Int; 57: 857-66.
Hawley JS, Robottom BJ, Weiner WJ. Multiple system atrophy. Rev Neurol Dis; 7: e45-55.
Hussl A, Mahlknecht P, Scherfler C, Esterhammer R, Schocke M, Poewe W, Seppi K. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy. Mov Disord; 25: 2444-9.
Jellinger KA, Lantos PL. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol; 119: 657-67.
Kawamura K, Shimohata T, Nakayama H, Tomita M, Ozawa T, Nishizawa M. Factors influencing the cognitive function in patients with multiple system atrophy. Mov Disord; 25: 2891-2.
Kikuchi A, Takeda A, Okamura N, Tashiro M, Hasegawa T, Furumoto S, Kobayashi M, Sugeno N, Baba T, Miki Y, Mori F, Wakabayashi K, Funaki Y, Iwata R, Takahashi S, Fukuda H, Arai H, Kudo Y, Yanai K, Itoyama Y. In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy. Brain; 133: 1772-8.
Kobayashi M, Nanri K, Tanaka N, Hasegawa A, Taguchi T, Saito K. [A case of autoimmune polyglandular syndrome-related Parkinsonian syndrome that required differentiation from multiple system atrophy]. Rinsho Shinkeigaku; 50: 704-9.
Kollensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Klockgether T, Yekhlef F, Tison F, Daniels C, Deuschl G, Coelho M, Sampaio C, Bozi M, Quinn N, Schrag A, Mathias CJ, Fowler C, Nilsson CF, Widner H, Schimke N, Oertel W, Del Sorbo F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Colosimo C, Meco G, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Rascol O, Kamm C, Gasser T, Siebert U, Poewe W, Wenning GK. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord; 25: 2604-12.
Lee JY, Yun JY, Shin CW, Kim HJ, Jeon BS. Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy. J Neurol; 257: 2065-70.
Levy R, Lozano AM, Lang AE, Dostrovsky JO. Event-related desynchronization of motor cortical oscillations in patients with multiple system atrophy. Exp Brain Res; 206: 1-13.
Lipp A, Schmelzer JD, Low PA, Johnson BD, Benarroch EE. Ventilatory and cardiovascular responses to hypercapnia and hypoxia in multiple-system atrophy. Arch Neurol; 67: 211-6.
Makioka K, Yamazaki T, Fujita Y, Takatama M, Nakazato Y, Okamoto K. Involvement of endoplasmic reticulum stress defined by activated unfolded protein response in multiple system atrophy. J Neurol Sci; 297: 60-5.
Marini C, Bandettini di Poggio M, Pomposelli E, Marchese R, Nobili F, Morbelli SD, Villa G, Abbruzzese G, Sambuceti G. Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging. Clin Nucl Med; 35: 311-6.
Matsuda H, Imabayashi E, Kuji I, Seto A, Ito K, Kikuta D, Yamada M, Shimano Y, Sato N. Evaluation of both perfusion and atrophy in multiple system atrophy of the cerebellar type using brain SPECT alone. BMC Med Imaging; 10: 17.
Meissner WG, Vital A, Ghorayeb I, Guehl D, Tison F. Dyspnea as first sign of autonomic failure in postmortem confirmed multiple system atrophy. Mov Disord; 25: 1997-8.
Minnerop M, Luders E, Specht K, Ruhlmann J, Schimke N, Thompson PM, Chou YY, Toga AW, Abele M, Wullner U, Klockgether T. Callosal tissue loss in multiple system atrophy--a one-year follow-up study. Mov Disord; 25: 2613-20.
Miwa H, Kondo T. Conjugal parkinsonism: multiple system atrophy and Parkinson's disease. Parkinsonism Relat Disord; 16: 232.
Miyatake S, Mochizuki H, Naka T, Ugawa Y, Tanabe H, Kuzume D, Suzuki M, Ogata K, Kawai M. Brain volume analyses and somatosensory evoked potentials in multiple system atrophy. J Neurol; 257: 419-25.
Nagaishi M, Yokoo H, Nakazato Y. Tau-positive glial cytoplasmic granules in multiple system atrophy. Neuropathology; 31: 299-305.
Nagaoka U, Shimizu T, Matsukura T, Takeda M. [Nutritional problems in multiple system atrophy--necessity of early tube feeding and caloric restriction at the advanced stage]. Rinsho Shinkeigaku; 50: 141-6.
Nagayama H, Ueda M, Yamazaki M, Nishiyama Y, Hamamoto M, Katayama Y. Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy. Mov Disord; 25: 1744-7.
Oz G, Iltis I, Hutter D, Thomas W, Bushara KO, Gomez CM. Distinct Neurochemical Profiles of Spinocerebellar Ataxias 1, 2, 6, and Cerebellar Multiple System Atrophy. Cerebellum.
Ozawa T, Saji E, Yajima R, Onodera O, Nishizawa M. Reduced bowel sounds in Parkinson's disease and multiple system atrophy patients. Clin Auton Res; 21: 181-4.
Ozawa T, Shinoda H, Tomita M, Shimohata T, Nakayama H, Nishizawa M. Tremulous arytenoid movements predict severity of glottic stenosis in multiple system atrophy. Mov Disord; 25: 1418-23.
Ozawa T, Tada M, Kakita A, Onodera O, Tada M, Ishihara T, Morita T, Shimohata T, Wakabayashi K, Takahashi H, Nishizawa M. The phenotype spectrum of Japanese multiple system atrophy. J Neurol Neurosurg Psychiatry; 81: 1253-5.
Paik MJ, Ahn YH, Lee PH, Kang H, Park CB, Choi S, Lee G. Polyamine patterns in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy. Clin Chim Acta; 411: 1532-5.
Park HJ, Bang G, Lee BR, Kim HO, Lee PH. Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy-parkinsonism. Cell Transplant.
Payoux P, Brefel-Courbon C, Ory-Magne F, Regragui W, Thalamas C, Balduyck S, Durif F, Azulay JP, Tison F, Blin O, Esquerre JP, Rascol O. Motor activation in multiple system atrophy and Parkinson disease: a PET study. Neurology; 75: 1174-80.
Pellecchia MT, Pivonello R, Colao A, Barone P. Is arginine test a reliable tool for differential diagnosis of multiple system atrophy? Ann Neurol; 68: 564-5; author reply 565-6.
Pellecchia MT, Pivonello R, Longo K, Manfredi M, Tessitore A, Amboni M, Pivonello C, Rocco M, Cozzolino A, Colao A, Barone P. Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system. Mov Disord; 25: 2621-6.
Pezzoli G, Tesei S, Canesi M, Sacilotto G, Vittorio M, Mizuno Y, Mochizuki H, Antonini A. The effect of repeated administrations of granulocyte colony stimulating factor for blood stem cells mobilization in patients with progressive supranuclear palsy, corticobasal degeneration and multiple system atrophy. Clin Neurol Neurosurg; 112: 65-7.
Pietzarka K, Reimann M, Schmidt C, Herting B, Schols L, Reichmann H, Berg D, Schrader C, Ziemssen T. The cold hand sign in multiple system atrophy: skin perfusion revisited. J Neural Transm; 117: 475-9.
Pinnock RA, McGivern RC, Forbes R, Gibson JM. An exploration of ocular fixation in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. J Neurol; 257: 533-9.
Reimann M, Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schoels L, Reichmann H, Berg D, Ziemssen T. Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. J Neural Transm; 117: 69-76.
Ross OA, Vilarino-Guell C, Wszolek ZK, Farrer MJ, Dickson DW. Reply to: SNCA variants are associated with increased risk of multiple system atrophy. Ann Neurol; 67: 414-5.
Sakakibara R, Kishi M, Ogawa E, Takahashi O, Sugiyama M, Uchiyama T, Yamamoto T, Yamanishi T. Multiple-system atrophy presenting with low rectal compliance and bowel pain. Mov Disord; 25: 1516-8.
Sakurai K, Kawaguchi T, Kawai T, Ogino H, Hara M, Okita K, Yamawaki T, Shibamoto Y. Usefulness of 3D-PRESTO imaging in evaluating putaminal abnormality in parkinsonian variant of multiple system atrophy. Neuroradiology; 52: 809-14.
Salazar G, Casas E, Oliveras D, Rando A, Sergio P. Ocular-jaw synkinesia in normal, Parkinson's disease, and multiple system atrophy subjects: Clinical and electrophysiological findings. Clin Neurophysiol; 121: 94-7.
Schrag A, Sheikh S, Quinn NP, Lees AJ, Selai C, Mathias C, Litvan I, Lang AE, Bower JH, Burn DJ, Low P, Jahanshahi M. A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy. Mov Disord; 25: 1077-81.
Seo JH, Yong SW, Song SK, Lee JE, Sohn YH, Lee PH. A case-control study of multiple system atrophy in Korean patients. Mov Disord; 25: 1953-9.
Shibata N, Inose Y, Toi S, Hiroi A, Yamamoto T, Kobayashi M. Involvement of 4-hydroxy-2-nonenal accumulation in multiple system atrophy. Acta Histochem Cytochem; 43: 69-75.
Song SK, Lee SK, Lee JJ, Lee JE, Choi HS, Sohn YH, Lee PH. Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy. Neurobiol Aging.
Suzuki M, Saigusa H, Shibasaki K, Kodera K. Multiple system atrophy manifesting as complex sleep-disordered breathing. Auris Nasus Larynx; 37: 110-3.
Swaminath PV, Ragothaman M, Koshy S, Sarangmath N, Adhyam M, Subbakrishna DK, Mathias CJ, Muthane UB. Urogenital symptoms in Parkinson's disease and multiple system atrophy-Parkinsonism: at onset and later. J Assoc Physicians India; 58: 86-90.
Swash M. Apraxia contributes to the motor deficit in Parkinson's Disease and multiple system atrophy. Eur J Neurol; 17: 346-7.
Tan EK, Chan LL. 'Diphasic' levodopa-induced chorea in multiple system atrophy. Int J Clin Pract; 64: 126-8.
Tha KK, Terae S, Yabe I, Miyamoto T, Soma H, Zaitsu Y, Fujima N, Kudo K, Sasaki H, Shirato H. Microstructural white matter abnormalities of multiple system atrophy: in vivo topographic illustration by using diffusion-tensor MR imaging. Radiology; 255: 563-9.
Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain; 133: 172-88.
Tseng YH, Chang WK. Multiple system atrophy and colon inertia. Mov Disord; 25: 1515-6.
Tzarouchi LC, Astrakas LG, Konitsiotis S, Tsouli S, Margariti P, Zikou A, Argyropoulou MI. Voxel-based morphometry and Voxel-based relaxometry in parkinsonian variant of multiple system atrophy. J Neuroimaging; 20: 260-6.
Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, Masliah E. Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy. Neuroreport; 21: 457-62.
Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, Whitney K, Masliah E. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci; 30: 6236-46.
Uluduz D, Erturk O, Kenangil G, Ozekmekci S, Ertan S, Apaydin H, Erginoz E. Apraxia in Parkinson's disease and multiple system atrophy. Eur J Neurol; 17: 413-8.
Van Laere K, Clerinx K, D'Hondt E, de Groot T, Vandenberghe W. Combined striatal binding and cerebral influx analysis of dynamic 11C-raclopride PET improves early differentiation between multiple-system atrophy and Parkinson disease. J Nucl Med; 51: 588-95.
Vidal JS, Vidailhet M, Derkinderen P, Tzourio C, Alperovitch A. Familial aggregation in atypical Parkinson's disease: a case control study in multiple system atrophy and progressive supranuclear palsy. J Neurol; 257: 1388-93.
Viscomi P, Jeffrey J. Development of clinical practice guidelines for patient management of blood pressure instability in multiple system atrophy, Parkinson's disease, and other neurological disorders. Can J Neurosci Nurs; 32: 6-19.
Wang PS, Wu HM, Lin CP, Soong BW. Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology.
Watanabe H, Ito M, Fukatsu H, Senda J, Atsuta N, Kaga T, Kato S, Katsuno M, Tanaka F, Hirayama M, Naganawa S, Sobue G. Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy. Mov Disord; 25: 1916-23.
Wenning GK, Colosimo C. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy. Rev Neurol (Paris); 166: 829-33.
Wu YT, Shyu KK, Jao CW, Wang ZY, Soong BW, Wu HM, Wang PS. Fractal dimension analysis for quantifying cerebellar morphological change of multiple system atrophy of the cerebellar type (MSA-C). Neuroimage; 49: 539-51.
Yamashita F, Hirayama M, Nakamura T, Takamori M, Hori N, Uchida K, Hama T, Sobue G. Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests. Clin Auton Res; 20: 191-7.
Yun JY, Lee WW, Lee JY, Kim HJ, Park SS, Jeon BS. SNCA variants and multiple system atrophy. Ann Neurol; 67: 554-5.
Zhang K, Zeng Y, Song C, Fu Y, Wan Q. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease. J Neurol; 257: 1486-91.